نتایج جستجو برای: experimental vaccine

تعداد نتایج: 816862  

2012
Glauce M. G. Rittner Julián E. Muñoz Alexandre F. Marques Joshua D. Nosanchuk Carlos P. Taborda Luiz R. Travassos

Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent invasive fungal disease in South America. Systemic mycoses are the 10th most common cause of death among infectious diseases in Brazil and PCM is responsible for more than 50% of deaths due to fungal infections. PCM is typically treated with sulfonamides, amphotericin B or azoles, although complete erad...

2011
Elda Righi Satoshi Kashiwagi Jianping Yuan Michael Santosuosso Pierre Leblanc Rachel Ingraham Benjamin Forbes Beth Edelblute Brian Collette Deyin Xing Magdalena Kowalski Maria Cristina Mingari Fabrizio Vianello Michael Birrer Sandra Orsulic Glenn Dranoff Mark C. Poznansky Marsha Rivkin

Vaccine and Immunotherapy Center, Infectious Diseases Medicine, Massachusetts General Hospital, Charlestown, MA Department of Experimental Medicine and IST Cancer Research, Genoa University, Italy Molecular Pathology, Massachusetts General Hospital, Boston, MA Department of Zoology, Clare College, Cambridge, UK Dept of Haematology, Padua University Hospital, Italy Gynecological Oncology Cancer ...

Journal: :Methods 2009
L Guilherme E Postol S Freschi de Barros F Higa R Alencar M Lastre C Zayas C R Puschel W R Silva L C Sa-Rocha V M Sa-Rocha O Pérez J Kalil

Streptococcus pyogenes causes severe invasive infections: the post-streptococcal sequelae of acute rheumatic fever (RF) and rheumatic heart disease (RHD), acute glomerulonephritis, and uncomplicated pharyngitis and pyoderma. Efforts to produce a vaccine against S. pyogenes began several decades ago, and different models have been proposed. Here, we describe the methodology used in the developme...

Journal: :Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2015
Michèle Anne Barocchi Rino Rappuoli

Thanks to the Global Alliance for Vaccines and Immunization (GAVI), the Vaccine Fund and the Bill & Melinda Gates Foundation, the global health community has made enormous progress in providing already existing vaccines to developing countries. However, there still exists a gap to develop vaccines for which there is no market in the Western world, owing to low economic incentives for the privat...

2017
Min-Eun Park Su-Hwa You Seo-Yong Lee Kwang-Nyeong Lee Mi-Kyeong Ko Joo-Hyung Choi Byounghan Kim Jong-Soo Lee Jong-Hyeon Park

With the current commercial foot-and-mouth disease vaccine, inoculating twice increases the formation of denatured meat due to granuloma or residual adjuvant at the injection site in pigs, resulting in economic loss. Therefore, we investigated protective antibody levels after reducing the amount of adjuvant in the vaccine. Field applicability of the experimental vaccine, made with a new adjuvan...

A. Bahrami A.M. Bahrami

  Humoral immune response of vaccine-I (supermatent from sonicated sporulated oocyst), vaccine –II (sediment from sonicated sporulated oocyst) and vaccine –III (un-sonicated sporulated oocyst) against conccidiosis in chickens was determined by indirect haemagglutination (IHA) test. IHA antibody titre was significantly higher (p

A.H. Dalimi D.D. Heath Gh.R. Karimi Gh.R. Motamedi H. Paykari

Vaccination of livestock with effective vaccine could be one of the control methods for hydatid cyst. In this study a new recombinant vaccine (Eg95) from New Zealand was prepared and used. Thirty health sheep from the same race and identical age and sex were selected. There was no history of any past vaccination or disease in selected animals. Animals were randomly categorized to four groups. O...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید